IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 30 June 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00375-08v1
76/9/4110    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Nallapareddy, S. R.
Right arrow Articles by Murray, B. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nallapareddy, S. R.
Right arrow Articles by Murray, B. E.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00375-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

A Functional Collagen Adhesin Gene, acm, in Clinical Isolates of Enterococcus faecium Correlates with the Recent Success of this Emerging Nosocomial Pathogen

Sreedhar R. Nallapareddy, Kavindra V. Singh, Pablo C. Okhuysen, and Barbara E. Murray*

Division of Infectious Diseases, Department of Internal Medicine; Center for the Study of Emerging and Re-emerging Pathogens; Department of Microbiology and Molecular Genetics, University of Texas Medical School, Houston, Texas 77030

* To whom correspondence should be addressed. Email: bem.asst{at}uth.tmc.edu.


   Abstract

Enterococcus faecium has recently evolved from a generally avirulent commensal into a multi-drug resistant healthcare associated pathogen causing difficult-to-treat infections, but little is known about the factors responsible for this change. We previously showed that some E. faecium express a cell-wall anchored collagen adhesin, Acm. Here, we analyzed 90 E. faecium isolates (99% acm+) and found that the Acm protein was detected predominantly in clinically-derived isolates, while the acm gene was present as a transposon interrupted pseudogene in 12 of 47 isolates of non-clinical origin. A highly significant association between clinical (versus fecal or food) origin and collagen adherence (P ≤ 0.0003) was also demonstrated and levels of adherence were highly correlated (r = 0.879) with the amount of cell surface Acm detected by whole-cell ELISA and flow cytometry. Thirty-seven of 41 sera from patients with E. faecium infections showed reactivity with recombinant Acm, while only 4 of 30 community and hospitalized control group sera reacted (P ≤ 0.0003); importantly, antibodies to Acm were present in all 14 E. faecium endocarditis patients' sera. Although pulsed-field gel electrophoresis indicated that multiple strains expressed collagen adherence, multilocus sequence typing demonstrated that the majority of collagen adhering isolates, as well as 16 of 17 endocarditis isolates, are part of the hospital-associated E. faecium genogroup referred to as clonal complex 17 (CC17) that has emerged globally. Taken together, our findings support the hypothesis that Acm has contributed to the emergence of E. faecium and CC17 in nosocomial infections.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.